A class-action lawsuit filed against Medtronic
(NYSE: MDT)
alleges that the company’s insulin delivery devices shared patient data with third parties.
The lawsuit, filed by plaintiff “A.H.,” levels allegations against Medtronic and its MiniMed and InPen devices. It addresses MiniMed’s transmission and disclosure of personally identifiable information and protected health information to Google and other third parties.
Per the lawsuit, the data was transmitted via tracking and authentication technology, including Google Analytics, Crashlytics, Firebase Authentication and related tools. A.H. says these technologies, installed on the website and/or mobile applications, includes the InPen iOS and Android applications.
“Information about a person’s health is among the most confidential and sensitive information in society, and its mishandling can have serious consequences, including embarrassment, discrimination, and denial of insurance coverage,” the lawsuit reads.
Get the full story at our sister site, Drug Delivery Business News.